CC BY-NC-ND 4.0 · J Lab Physicians 2021; 13(03): 219-223
DOI: 10.1055/s-0041-1730878
Original Article

Bisalbuminemia: A Pathologist’s Insight of an Uncommon Phenomenon

Gargi Kapatia
1   Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
Monika Wadhwa
2   Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
Pankaj Malhotra
2   Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
Gaurav Prakash
1   Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
Ritu Aggarwal
1   Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
› Author Affiliations
 

Abstract

Background The incidence of a bifid electrophoretic pattern in the albumin region on serum protein electrophoresis is an infrequent phenomenon. The availability of literature from India is scarce and is limited to case reports.

Objective The aim of the study is to analyze the frequency of bisalbuminemia in an Indian referral facility. The study delved into their clinical associations.

Material and Methods The retrospective case records of the patient from the departmental database were scrutinized. The study subjects were for an 8-year study period.

Results There were about 39,900 serum electrophoresis performed in an 8-year study period. A total of 40 cases of bisalbuminemia were detected. The incidence in our cohort was 0.01%.

Conclusion Bisalbuminemia, an overtly benign condition, is infrequent in Indian population although not rare. It is associated with several clinical disorders; however, the association seems to be plausibly coincidental.


#

Introduction

Human serum albumin (HSA) is a vital constituent of human plasma with a variety of physiological functions. Besides being essential, HSA constitutes 60 to 65% of total plasma proteins.[1] HSA’s role in maintaining oncotic pressure is well known. In addition, HSA helps in transportation of several endogenous and exogenous molecules.[2] Its antioxidant function protects the body from several oxidizing agents. It acts as catalyst in various body reactions.[2] It is produced in the liver by hepatocytes as a 66.5 kDa single polypeptide chain and is secreted into plasma without glycosylation. Structurally, it is comprised of 585 amino acid residues with 67% α-helix and without β-sheet. It has three homologous domains and each domain is further comprised of two subdomains (A and B).[3]

Serum protein electrophoresis (SPEP) is an investigative procedure which is performed routinely for diagnostic purpose, specifically as a screening test for monoclonal gammopathies. However, we come across infrequent samples which have two bands in the albumin region on the agarose gel electrophoresis and this pattern is termed as bisalbuminemia or alloalbuminemia. This phenomenon was first described in the year 1955 by Scheurlen in a diabetic German patient. This gives rise to two separate albumin peaks because of their dissimilar mobilities on SPEP.[4] The incidence of these variants is usually stated to be 1:1000 to 1:3000.[1] The incidence is reported to be high (1:100) in several tribes of North American Indians.[5] In this study, we wanted to evaluate the frequency of bisalbuminemia among patient undergoing screening in our laboratory. As immunopathologists, we were inquisitive regarding its translational importance. Hence, in the present study in addition to frequency, we tried to analyze the disease association in a cohort of patient with bisalbuminemia.


#

Materials and Methods

The study presents retrospectively analyzed data from departmental case records and meets the conditions of the World Medical Association Declaration of Helsinki. This study includes 40 cases of bisalbuminemia diagnosed on SPEP. In the present study, we included all electrophoretically diagnosed cases of bisalbuminemia (n = 40) in the Department of Immunopathology of Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh from January 2012 to December 2019. SPEP was conducted with agarose gel electrophoresis on Helena Bioscience (Europe) platform. The kits utilized for running the test were SAS-1 plus and SAS-2 SAS-1SP 24 SB kit.[6] The proteins were separated on the gel on the basis of their electrical charges (pH-8.8). The separation of the band is aided by electrophoretic and electroendosmotic forces. The agarose gel was loaded with test sample with the help of applicators, and the remainder of the steps were automated. Subsequently, the gel was loaded on to the SAS-2 apparatus. In this, the steps of staining, destaining, and drying were automated. The analysis was performed by scanning the gel using software from Helena Biosciences Europe software PT, version 3.0. The resolution was obtained as six bands: albumin, alpha-1 globulins, alpha-2 globulins, beta-1 globulins, beta-2 globulins, and gamma globulins. Data including clinical findings, biochemical parameters, and hemogram were recovered from the medical records of each patient.


#

Results

There were a total 39,900 SPEPs performed and 40 cases of bisalbuminemia were diagnosed over a span of 8 years. The incidence of bisalbuminemia in our cohort was 0.01% (1:1,000). The mean age was 52.2 years (range 13–85 years). There was male preponderance with 13 females and 27 males. The clinicopathological details of all the cases have been highlighted in [Table 1]. Patients presented with variable clinical features. The mean hemoglobin was 9.3 g/dL (6.8–12.1 g/dL). Diabetes mellitus (DM) was the most common co-existing clinical condition with bisalbuminemia in our cohort (n = 6), followed by tuberculosis (n = 3) and multiple myeloma (n = 3). Other less common co-existing conditions were liver cirrhosis, lung abscess, chronic kidney disease (CKD), acute kidney injury, nephrotic syndrome, dengue, and lung adenocarcinoma.

Table 1

Clinical and SPEP findings of all the cases

S. no.

Age (in years)

Sex

Clinical history

SPEP findings in addition to bisalbuminemia

Abbreviations: DVT, deep vein thrombosis; SPEP, serum protein electrophoresis.

? denotes possible diagnosis

1

28

Female

Cirrhosis with portal hypertension, chronic Budd Chiari syndrome, ascites, vitamin D deficiency

Mild hypergammaglobulinemia

2

42

Male

Lung abscess, fever, cough

Mild hypergammaglobulinemia

3

38

Male

Marked hypergammaglobulinemia

4

52

Female

Chronic kidney disease, hypertension, swelling of body

Normal pattern

5

30

Female

Mild hypergammaglobulinemia

6

55

Male

Primary hyperthyroidism, acute kidney injury, hypertension, alcoholic liver disease, contrast nephropathy

Mild prominence of alpha 2 globulins

7

55

Male

Mild hypergammaglobulinemia

8

85

Male

Diabetes mellitus, diabetic nephropathy

Moderate hypergammaglobulinemia

9

56

Male

Distal neuropathy

Normal pattern

10

50

Female

Hypercalcemia and renal failure

Mild hypergammaglobulinemia and mild prominence of alpha 2 globulins

11

64

Male

Normal pattern

12

48

Male

? Amyloidosis

Normal pattern

13

57

Male

Hypertension, nephrotic syndrome

Normal pattern

14

67

Male

Tuberculosis, fever, cough

Mild hypergammaglobulinemia

15

50

Female

Tuberculosis, pericardial effusion, DVT, fever with cough

Normal pattern

16

70

Male

Multiple myeloma

M band in gamma region in background of marked hypogammaglobulinemia

17

56

Male

Rapidly progressive renal failure with increase in creatinine

Mild hypergammaglobulinemia

18

66

Female

Normal pattern

19

45

Male

Brachial plexopathy, diabetes mellitus

Normal pattern

20

55

Male

Normal pattern

21

70

Female

Metastatic adenocarcinoma with pleural and pericardial effusion and lymphocytic thyroiditis

Mild prominence of alpha 2 globulins and moderate hypergammaglobulinemia

22

55

Male

Normal pattern

23

57

Male

Hypertension, diabetes mellitus with pedal edema

Mild hypergammaglobulinemia

24

40

Male

Normal pattern

25

52

Male

Tuberculosis

Moderate hypergammaglobulinemia

26

58

Male

Normal pattern

27

40

Female

Cryoglobulinemic vasculitis

Normal pattern

28

61

Male

Mild hypergammaglobulinemia along with bisalbuminuria

29

62

Male

Diabetes mellitus with chronic inflammatory demyelinating neuropathy

Normal pattern

30

49

Male

Hypertension, diabetes mellitus

Mild hypergammaglobulinemia

31

50

Male

Normal pattern

32

42

Male

Normal pattern

33

65

Female

Diabetes mellitus

Normal pattern

34

60

Female

Previous known case of multiple myeloma

Mild hypergammaglobulinemia

35

51

Male

Normal pattern

36

45

Female

? Multiple myeloma (anemia and renal failure)

Mild hypergammaglobulinemia

37

53

Female

Renal failure

Mild hypergammaglobulinemia

38

51

Male

? Multiple myeloma (anemia, renal failure, fatigue, backache)

M band in gamma region in background of normal gamma globulins

39

45

Female

? Multiple myeloma

M band in gamma region in background of marked hypogammaglobulinemia

40

13

Male

Dengue with ? Reactive arthritis

Mild prominence of alpha 2 globulins and marked hypergammaglobulinemia

On electrophoresis, all the cases showed presence of two bands in the albumin region. In addition, mild hypergammaglobulinemia was seen in 13 cases, moderate hypergammaglobulinemia in three cases, and marked hypergammaglobulinemia in two cases. There were 18 cases where the electrophoretic pattern was observed to be normal. There was increased expression of alpha 2 globulins in four cases. There was coexistence of myeloma protein (M band) in three cases ([Fig. 1]). Another case demonstrated bisalbuminuria in addition to bisalbuminemia ([Fig. 2]).

Zoom Image
Fig. 1 Densitometer tracing showing two peaks in the albumin region and M band on serum electrophoresis along with gel picture of bisalbuminemia with M band.
Zoom Image
Fig. 2 Serum and urine electrophoresis gel showing bisalbuminemia and bisalbuminuria, respectively.

#

Discussion

This infrequently detected overtly nonpathogenic finding can be either acquired or inherited. The hereditary bisalbuminemia is permanent and reflects the coexistence of two types of albumin. Overall, it has rare consequences in terms of morbidity, but some variants may have a different affinity from that of albumin to normal hormones, metal ions, fatty acids, or drugs.[7] [8] Conversely, the acquired bisalbuminemia occurs as a transitory phenomenon and shows a faster mobility toward the anode as compared with normal albumin. This variance reflects the presence of a normal albumin and a modified albumin. They result from structural changes of a portion of albumin circulating either by addition or subtraction of material.[8] Other causes include DM, Waldenstrom macroglobulinemia, multiple myeloma, sarcoidosis, pancreatic pseudocyst, nephrotic syndrome, CKD, and in patients on high doses of penicillin.[9] [10] [11] [12] In pancreatic pseudocyst, protein lysis by pancreatic enzymes would be responsible for the double peak.[10] The beta-lactams can bind to albumin and change its electrophoretic migration.[13] Diabetes has been associated with bisalbuminemia, though the exact cause is not known.[14] Monoclonal gammopathies including myelomas may be randomly seen with bisalbuminemia,[15] though nobody talks about the reason for the same. Chan et al[16] found that bisalbuminemia is a rare incidental finding in monoclonal gammopathies and is not associated with the same. Bisalbuminuria is a rarer finding which shows two distinct fractions of urinary albumin on electrophoresis. There are just few case reports of the same.[17] [18] We have also described one case in our series which showed both bisalbuminemia and bisalbuminuria.

When we see inherited types, one demonstrates either slow (with less negative net charge) or fast (with more negative net charge) electrophoretic mobility.[19] Contrastingly, the acquired form displays presence of albumin dimers—an extra band in the immediate post-albumin region signifying 10 to 15% of the total albumin fraction. Inherited forms may show single point (e.g., arginyl–albumin resulting from the substitution of arginine [Arg] in place of normal amino-terminal aspartic acid moiety) or chain-termination mutations (a mutation in the amino-terminal Arg–Arg propeptide sequence required for post-transcriptional processing of albumin).[20] In our cohort, there is predominant North Indian population admixed with Caucasian population. In our population cohort, there does not seem to be any association due to variable presentation. Therefore, bisalbuminemia is not a product of any disease but a chance finding which could be attributed to possibly hereditary type.

Albumin variations, as detected on SPEP, should keenly be noticed by both the clinicians and immunopathologists. Such novel forms of albumin may also offer data on evolution, molecular structure, and characteristics of the albumin molecule. Acquired form should arouse suspicion and make clinician think if there is any underlying disease process going on which is not diagnosed yet. Learning about albumin variants can be of great inquisitiveness and might be valuable in assessing their geographical distribution. There is no well-known clinical importance of this entity except stated above. It should not be mistaken as an abnormal globulin peak specially while seeing suspected or confirmed cases of monoclonal gammopathies. These bands usually vanish after the stoppage of drug or the treatment of disease.[21] [22] Some of the albumin variants show altered affinity for several ligands, like steroidal hormones, thyroxine, and many drugs.[21] [23] [24] Therefore, it is important to recognize such variants which may further provide more knowledge about the nature of diseases related with atypical binding of these ligands to albumin. Clinicians and immunopathologists must keep this entity in their radar and interpret it with caution.


#
#

Conflict of Interest

None declared.

  • References

  • 1 Peters Jr T. All About Albumin: Biochemistry, Genetics and Medical Applications. San Diego, CA: Academic Press 1996
  • 2 Kragh-Hansen U, Minchiotti L, Galliano M. Peters T Jr. Human serum albumin isoforms: genetic and molecular aspects and functional consequences. Biochim Biophys Acta 2013; 1830 (12) 5405-5417
  • 3 Ha CE, Bhagavan NV. Novel insights into the pleiotropic effects of human serum albumin in health and disease. Biochim Biophys Acta 2013; 1830 (12) 5486-5493
  • 4 Kim YH, Lee YW, Jeon BR. et al Clinical characteristics and ALB gene mutation analysis of Korean patients with bisalbuminemia. Korean J Lab Med 2010; 30 (03) 307-311
  • 5 Takahashi N, Takahashi Y, Isobe T. et al Amino acid substitutions in inherited albumin variants from Amerindian and Japanese populations. Proc Natl Acad Sci U S A 1987; 84 (22) 8001-8005
  • 6 Sharma S, Gupta P, Aggarwal R, Malhotra P, Minz RW, Bansal F. Demystifying biclonal gammopathy: a pathologist’s perspective. Lab Med 2019; 50 (04) 357-363
  • 7 AvRuskin TW, Juan CS, Weiss RE. Familial dysalbuminemic hyperthyroxinemia: a rare example of albumin polymorphism and its rapid molecular diagnosis. J Pediatr Endocrinol Metab 2002; 15 (06) 801-807
  • 8 Tance Y, Deneuville T, Tiev KP. et al Un pic transitoire sur l’électrophorèse des protides sériques. Rev Med Interne 2009; 30 (05) 436-437
  • 9 Šimundić A, Miler M, Nikolac N. et al Bisalbuminemia in a male Croatian patient with sarcoidosis. Biochem Med (Zagreb) 2009; 19: 95-100
  • 10 Ejaz AA, Krishna M, Wasiluk A, Knight JD. Bisalbuminemia in chronic kidney disease. Clin Exp Nephrol 2004; 8 (03) 270-273
  • 11 Kalambokis G, Kitsanou M, Kalogera C, Kolios G, Seferiadis K, Tsianos E. Inherited bisalbuminemia with benign monoclonal gammopathy detected by capillary but not agarose gel electrophoresis. Clin Chem 2002; 48 (11) 2076-2077
  • 12 Shetty JK, Prakash M, Gopalakrishna K. Bisalbuminemia in an adult male with Alzheimer’s disease. Indian J Med Sci 2007; 61 (06) 356-357
  • 13 Winter V, Rosenvall A, Heikkilä S, von Essen R. Acquired bisalbuminemia in staphylococcal endocarditis treated with dicloxacillin. Scand J Infect Dis 1992; 24 (06) 811-814
  • 14 Shetty JK, Maradi R, Prabhu K, Bhat G. Bisalbuminemia in a hypothyroid patient with diabetes: a case report. J Clin Diagn Res 2015; 9 (09) BD01-BD02
  • 15 Pola V, Tichý M. Bisalbuminemia. Critical review and report of a case of an acquired form in a myeloma patient. Folia Haematol Int Mag Klin Morphol Blutforsch 1985; 112 (01) 208-218
  • 16 Chan PC, Yasodhara A, Truong D. Bisalbuminemia: lack of association with monoclonal gammopathy and value-justification for reporting in serum protein electrophoresis. J Clin Chem Lab Med 2017; 1: 108
  • 17 Hoang MP, Baskin LB, Wians FH Jr. Bisalbuminuria in an adult with bisalbuminemia and nephrotic syndrome. Clin Chim Acta 1999; 284 (01) 101-107
  • 18 Al-Sarraf A, Chow C, Garg A. Bisalbuminuria detected by agarose gel electrophoresis. Clin Biochem 2010; 43 (4-5) 534-536
  • 19 Jamieson GA, Ganguly P. Studies on a genetically determined albumin dimer. Biochem Genet 1969; 3 (04) 403-416
  • 20 Faviou E, Nounopoulos C, Dionyssiou-Asteriou A. Bisalbuminemia from a clinical chemist’s viewpoint: a case report and review of the recent literature. Minerva Med 2006; 97 (03) 287-293
  • 21 Arvan DA, Blumberg BS, Melartin L. Transient “bisalmuminemia” induced by drugs. Clin Chim Acta 1968; 22 (02) 211-218
  • 22 Kobayashi S, Okamura N, Kamoi K, Sugita O. Bisalbumin (fast and slow type) induced by human pancreatic juice. Ann Clin Biochem 1995; 32 (Pt 1) 63-67
  • 23 Kragh-Hansen U, Minchiotti L, Brennan SO, Sugita O. Hormone binding to natural mutants of human serum albumin. Eur J Biochem 1990; 193 (01) 169-174
  • 24 Kragh-Hansen U, Brennan SO, Galliano M, Sugita O. Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations. Mol Pharmacol 1990; 37 (02) 238-242

Address for correspondence

Ritu Aggarwal, MD
Department of Immunopathology, Postgraduate Institute of Medical Education and Research (PGIMER)
Chandigarh 160012
India   

Publication History

Article published online:
16 June 2021

© 2021. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

  • References

  • 1 Peters Jr T. All About Albumin: Biochemistry, Genetics and Medical Applications. San Diego, CA: Academic Press 1996
  • 2 Kragh-Hansen U, Minchiotti L, Galliano M. Peters T Jr. Human serum albumin isoforms: genetic and molecular aspects and functional consequences. Biochim Biophys Acta 2013; 1830 (12) 5405-5417
  • 3 Ha CE, Bhagavan NV. Novel insights into the pleiotropic effects of human serum albumin in health and disease. Biochim Biophys Acta 2013; 1830 (12) 5486-5493
  • 4 Kim YH, Lee YW, Jeon BR. et al Clinical characteristics and ALB gene mutation analysis of Korean patients with bisalbuminemia. Korean J Lab Med 2010; 30 (03) 307-311
  • 5 Takahashi N, Takahashi Y, Isobe T. et al Amino acid substitutions in inherited albumin variants from Amerindian and Japanese populations. Proc Natl Acad Sci U S A 1987; 84 (22) 8001-8005
  • 6 Sharma S, Gupta P, Aggarwal R, Malhotra P, Minz RW, Bansal F. Demystifying biclonal gammopathy: a pathologist’s perspective. Lab Med 2019; 50 (04) 357-363
  • 7 AvRuskin TW, Juan CS, Weiss RE. Familial dysalbuminemic hyperthyroxinemia: a rare example of albumin polymorphism and its rapid molecular diagnosis. J Pediatr Endocrinol Metab 2002; 15 (06) 801-807
  • 8 Tance Y, Deneuville T, Tiev KP. et al Un pic transitoire sur l’électrophorèse des protides sériques. Rev Med Interne 2009; 30 (05) 436-437
  • 9 Šimundić A, Miler M, Nikolac N. et al Bisalbuminemia in a male Croatian patient with sarcoidosis. Biochem Med (Zagreb) 2009; 19: 95-100
  • 10 Ejaz AA, Krishna M, Wasiluk A, Knight JD. Bisalbuminemia in chronic kidney disease. Clin Exp Nephrol 2004; 8 (03) 270-273
  • 11 Kalambokis G, Kitsanou M, Kalogera C, Kolios G, Seferiadis K, Tsianos E. Inherited bisalbuminemia with benign monoclonal gammopathy detected by capillary but not agarose gel electrophoresis. Clin Chem 2002; 48 (11) 2076-2077
  • 12 Shetty JK, Prakash M, Gopalakrishna K. Bisalbuminemia in an adult male with Alzheimer’s disease. Indian J Med Sci 2007; 61 (06) 356-357
  • 13 Winter V, Rosenvall A, Heikkilä S, von Essen R. Acquired bisalbuminemia in staphylococcal endocarditis treated with dicloxacillin. Scand J Infect Dis 1992; 24 (06) 811-814
  • 14 Shetty JK, Maradi R, Prabhu K, Bhat G. Bisalbuminemia in a hypothyroid patient with diabetes: a case report. J Clin Diagn Res 2015; 9 (09) BD01-BD02
  • 15 Pola V, Tichý M. Bisalbuminemia. Critical review and report of a case of an acquired form in a myeloma patient. Folia Haematol Int Mag Klin Morphol Blutforsch 1985; 112 (01) 208-218
  • 16 Chan PC, Yasodhara A, Truong D. Bisalbuminemia: lack of association with monoclonal gammopathy and value-justification for reporting in serum protein electrophoresis. J Clin Chem Lab Med 2017; 1: 108
  • 17 Hoang MP, Baskin LB, Wians FH Jr. Bisalbuminuria in an adult with bisalbuminemia and nephrotic syndrome. Clin Chim Acta 1999; 284 (01) 101-107
  • 18 Al-Sarraf A, Chow C, Garg A. Bisalbuminuria detected by agarose gel electrophoresis. Clin Biochem 2010; 43 (4-5) 534-536
  • 19 Jamieson GA, Ganguly P. Studies on a genetically determined albumin dimer. Biochem Genet 1969; 3 (04) 403-416
  • 20 Faviou E, Nounopoulos C, Dionyssiou-Asteriou A. Bisalbuminemia from a clinical chemist’s viewpoint: a case report and review of the recent literature. Minerva Med 2006; 97 (03) 287-293
  • 21 Arvan DA, Blumberg BS, Melartin L. Transient “bisalmuminemia” induced by drugs. Clin Chim Acta 1968; 22 (02) 211-218
  • 22 Kobayashi S, Okamura N, Kamoi K, Sugita O. Bisalbumin (fast and slow type) induced by human pancreatic juice. Ann Clin Biochem 1995; 32 (Pt 1) 63-67
  • 23 Kragh-Hansen U, Minchiotti L, Brennan SO, Sugita O. Hormone binding to natural mutants of human serum albumin. Eur J Biochem 1990; 193 (01) 169-174
  • 24 Kragh-Hansen U, Brennan SO, Galliano M, Sugita O. Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations. Mol Pharmacol 1990; 37 (02) 238-242

Zoom Image
Fig. 1 Densitometer tracing showing two peaks in the albumin region and M band on serum electrophoresis along with gel picture of bisalbuminemia with M band.
Zoom Image
Fig. 2 Serum and urine electrophoresis gel showing bisalbuminemia and bisalbuminuria, respectively.